| 8 | Temozolomide (Temodar)FDA LinkGeneric
06/2022
-
01/2013 |
| 7 | Carmustine (FIVB)FDA Link
01/2016
-
05/2010 |
| 6 | Proteins (Proteins, Gene)FDA Link
06/2021
-
11/2015 |
| 3 | Doxorubicin (Adriamycin)FDA LinkGeneric
06/2021
-
06/2012 |
| 3 | DNA (Deoxyribonucleic Acid)IBA
04/2019
-
11/2016 |
| 3 | Epirubicin (Ellence)FDA LinkGeneric
01/2019
-
09/2013 |
| 3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015
-
03/2013 |
| 3 | OxidesIBA
08/2014
-
07/2013 |
| 2 | LigandsIBA
05/2024
-
01/2020 |
| 2 | Fluorescein (Funduscein)FDA LinkGeneric
01/2024
-
01/2016 |
| 2 | Therapeutic UsesIBA
01/2024
-
04/2019 |
| 2 | LipidsIBA
12/2022
-
11/2022 |
| 2 | Nuclear Receptor Co-Repressor 1IBA
06/2022
-
01/2022 |
| 2 | EnzymesIBA
01/2022
-
01/2021 |
| 2 | Messenger RNA (mRNA)IBA
01/2021
-
01/2019 |
| 2 | ErbB Receptors (EGF Receptor)IBA
01/2021
-
09/2013 |
| 2 | RNA (Ribonucleic Acid)IBA
11/2019
-
03/2012 |
| 2 | Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
09/2019
-
10/2016 |
| 2 | 6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
04/2019
-
01/2019 |
| 2 | Cell-Penetrating PeptidesIBA
04/2019
-
01/2019 |
| 2 | Liposomes (Liposome)IBA
01/2018
-
10/2016 |
| 2 | Contrast MediaIBA
10/2016
-
08/2014 |
| 2 | graphene oxideIBA
05/2015
-
01/2012 |
| 1 | Silicon Dioxide (Silica)FDA LinkGeneric
05/2024 |
| 1 | AcidsIBA
01/2024 |
| 1 | Angiotensin-Converting Enzyme 2IBA
11/2023 |
| 1 | Acrolein (Aqualin)IBA
10/2023 |
| 1 | CytokinesIBA
10/2023 |
| 1 | Phospholipids (Phosphatides)FDA LinkGeneric
12/2022 |
| 1 | Ether (Diethyl Ether)IBA
12/2022 |
| 1 | Phosphatidylcholines (Phosphatidylcholine)IBA
12/2022 |
| 1 | SphingolipidsIBA
12/2022 |
| 1 | CeramidesIBA
12/2022 |
| 1 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 |
| 1 | ApoferritinsIBA
06/2021 |
| 1 | Ferritins (Ferritin)IBA
06/2021 |
| 1 | IntegrinsIBA
06/2021 |
| 1 | Transferrin Receptors (Transferrin Receptor)IBA
06/2021 |
| 1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021 |
| 1 | FucosyltransferasesIBA
01/2021 |
| 1 | Valproic Acid (Depakote)FDA LinkGeneric
01/2021 |
| 1 | Proto-Oncogene Proteins c-metIBA
01/2021 |
| 1 | Sulfhydryl Compounds (Thiols)IBA
10/2020 |
| 1 | Glutathione (Reduced Glutathione)IBA
10/2020 |
| 1 | Uric Acid (Urate)IBA
09/2020 |
| 1 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2020 |
| 1 | Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020 |
| 1 | gamma-glutamylaminomethylsulfonic acid (GAMS)IBA
01/2020 |
| 1 | Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2020 |
| 1 | CC ChemokinesIBA
01/2020 |
| 1 | CalciumIBA
01/2020 |
| 1 | Conditioned Culture MediaIBA
01/2020 |
| 1 | Small Interfering RNA (siRNA)IBA
11/2019 |
| 1 | SynucleinsIBA
10/2019 |
| 1 | polyglutamineIBA
09/2019 |
| 1 | ApolipoproteinsIBA
04/2019 |
| 1 | Peptides (Polypeptides)IBA
04/2019 |
| 1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2019 |
| 1 | HLA-DR Antigens (HLA-DR)IBA
01/2019 |
| 1 | Granzymes (Granzyme)IBA
01/2019 |
| 1 | Ganciclovir (Cytovene)FDA LinkGeneric
10/2017 |
| 1 | Firefly LuciferasesIBA
10/2017 |
| 1 | Thymidine KinaseIBA
10/2017 |
| 1 | Folic Acid (Vitamin M)FDA LinkGeneric
11/2016 |
| 1 | Bevacizumab (Avastin)FDA Link
10/2016 |
| 1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2016 |
| 1 | Monoclonal AntibodiesIBA
10/2016 |
| 1 | GalliumIBA
10/2016 |
| 1 | isothiocyanic acidIBA
01/2016 |
| 1 | Biomarkers (Surrogate Marker)IBA
01/2016 |
| 1 | Amyloid beta-PeptidesIBA
01/2016 |
| 1 | Bovine Serum AlbuminIBA
01/2016 |
| 1 | fluorescein isothiocyanate bovine serum albuminIBA
01/2016 |
| 1 | CurcuminIBA
11/2015 |
| 1 | Interleukin-12 (IL 12)IBA
01/2015 |